These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11861684)

  • 1. Dystonia in multiple system atrophy.
    Boesch SM; Wenning GK; Ransmayr G; Poewe W
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):300-3. PubMed ID: 11861684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk].
    Nakanishi I; Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2003 Jul; 55(7):605-8. PubMed ID: 12910995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young-onset multiple system atrophy: Clinical and pathological features.
    Batla A; De Pablo-Fernandez E; Erro R; Reich M; Calandra-Buonaura G; Barbosa P; Balint B; Ling H; Islam S; Cortelli P; Volkmann J; Quinn N; Holton JL; Warner TT; Bhatia KP
    Mov Disord; 2018 Jul; 33(7):1099-1107. PubMed ID: 30153390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple system atrophy: an update.
    Wenning GK; Geser F; Stampfer-Kountchev M; Tison F
    Mov Disord; 2003 Sep; 18 Suppl 6():S34-42. PubMed ID: 14502654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
    Luquin MR; Scipioni O; Vaamonde J; Gershanik O; Obeso JA
    Mov Disord; 1992; 7(2):117-24. PubMed ID: 1350058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinsonism and dropped head: dystonia, myopathy or both?
    Savica R; Kumar N; Ahlskog JE; Josephs KA; Matsumoto JY; McKeon A
    Parkinsonism Relat Disord; 2012 Jan; 18(1):30-4. PubMed ID: 21873101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy.
    Okusa S; Nakahara J; Seki M
    Intern Med; 2024 Sep; 63(17):2451-2453. PubMed ID: 38311425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.
    Roncevic D; Palma JA; Martinez J; Goulding N; Norcliffe-Kaufmann L; Kaufmann H
    J Neural Transm (Vienna); 2014 May; 121(5):507-12. PubMed ID: 24337696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young-onset multiple system atrophy.
    Kim HJ; Jeon BS; Lee JY; Yun JY; Kim YE; Paek SH
    J Neurol Sci; 2012 Aug; 319(1-2):168-70. PubMed ID: 22607745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.
    Yabe I; Soma H; Takei A; Fujiki N; Yanagihara T; Sasaki H
    J Neurol Sci; 2006 Nov; 249(2):115-21. PubMed ID: 16828805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orofacial dystonia and asssociated bulbar symptoms in multiple system atrophy: A blinded video analysis.
    Thongchuam Y; Panyakaew P; Bhidayasiri R
    J Neurol Sci; 2020 Oct; 417():116992. PubMed ID: 32622521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia.
    Ueno SI; Oyama G; Kanai K; Hatano T; Shimo Y; Hattori N
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():6. PubMed ID: 32775020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features.
    Ishida C; Takahashi K; Kato-Motozaki Y; Tagami A; Komai K
    Intern Med; 2021 Feb; 60(3):367-372. PubMed ID: 32963152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of dystonia in atypical parkinsonism.
    Godeiro-Junior C; Felício AC; Barsottini OG; Aguiar PM; Silva SM; Borges V; Ferraz HB
    Arq Neuropsiquiatr; 2008 Dec; 66(4):800-4. PubMed ID: 19099114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease.
    Calandra-Buonaura G; Doria A; Lopane G; Guaraldi P; Capellari S; Martinelli P; Cortelli P; Contin M
    J Neurol; 2016 Feb; 263(2):250-256. PubMed ID: 26566913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report.
    Chou KL; Forman MS; Trojanowski JQ; Hurtig HI; Baltuch GH
    J Neurosurg; 2004 Mar; 100(3):553-6. PubMed ID: 15035294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.
    Lin DJ; Hermann KL; Schmahmann JD
    Cerebellum; 2016 Dec; 15(6):663-679. PubMed ID: 26467153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Video Representation of Dopamine-Responsive Multiple System Atrophy Cerebellar Type.
    Doan J; Sheikh I; Elmer L; Rashid M
    Am J Case Rep; 2021 Nov; 22():e933995. PubMed ID: 34776506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple system atrophy].
    Damon-Perrière N; Tison F; Meissner WG
    Psychol Neuropsychiatr Vieil; 2010 Sep; 8(3):179-91. PubMed ID: 20739256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.